| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872472 | The Annals of Thoracic Surgery | 2014 | 8 Pages |
Abstract
Patients with clinical stage IA non-small cell lung cancer treated by SBRT appear to have higher overall disease recurrence than those treated by wedge resection. However, there was no significant difference in disease-free survival. A randomized trial is needed to define the role of SBRT in the potentially operable patient.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jeffrey L. MD, Bhupesh MD, Nonso MD, Abu MS, Paul C. MD, Subroto MD, Brendon M. MD, Nasser K. MD,